---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-003812"
form_type: "8-K"
ticker: "SCNX"
cik: "0001382574"
company_name: "Scienture Holdings, Inc."
filed_at: "2025-04-11T23:59:59+00:00"
generated_at: "2026-05-23T15:58:29.863766+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Scienture divests IPS and Bonum to Tollo for $5M note; focuses on Specialty Pharma

## Summary
- Total consideration is $5M in a promissory note bearing interest at prime rate, maturing June 30, 2030.
- Closing expected June 30, 2025; Tollo must pay 20% of future equity proceeds toward the note.
- CEO Suren Ajjarapu and President Prashant Patel have beneficial interest in buyer Tollo (related party).
- Proceeds will fund high-growth product development at Scienture, LLC subsidiary.
- Divestiture includes legacy Healthcare IT (IPS, Bonum, Softell) to streamline operations.

## SEC filing metadata
- accession: 0001641172-25-003812
- form_type: 8-K
- ticker: SCNX
- cik: 0001382574
- company_name: Scienture Holdings, Inc.
- filed_at: 2025-04-11T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1382574/000164117225003812/0001641172-25-003812-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1382574/000164117225003812/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-003812
- JSON: https://secwatch.observer/filing/0001641172-25-003812.json
- Plain text: https://secwatch.observer/filing/0001641172-25-003812.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.